HomeCompareHGGCF vs PFE

HGGCF vs PFE: Dividend Comparison 2026

HGGCF yields 1000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HGGCF wins by $18844438.63M in total portfolio value
10 years
HGGCF
HGGCF
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full HGGCF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — HGGCF vs PFE

📍 HGGCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHGGCFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HGGCF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HGGCF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HGGCF
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, HGGCF beats the other by $13,384,783,372,182.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HGGCF + PFE for your $10,000?

HGGCF: 50%PFE: 50%
100% PFE50/50100% HGGCF
Portfolio after 10yr
$9422219.36M
Annual income
$7,873,402,009,895.54/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HGGCF
No analyst data
Altman Z
6.7
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HGGCF buys
0
PFE buys
0
No recent congressional trades found for HGGCF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHGGCFPFE
Forward yield1000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$18844438.68M$49.6K
Annual income after 10y$15,746,803,993,532.36$26,258.71
Total dividends collected$18607754.73M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HGGCF vs PFE ($10,000, DRIP)

YearHGGCF PortfolioHGGCF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$110,700$100,000.00$9,153$693.39+$101.5KHGGCF
2$1,153,028$1,034,579.44$8,593$849.25+$1.14MHGGCF
3$11,304,737$10,070,996.94$8,336$1,066.78+$11.30MHGGCF
4$104,376,400$92,280,331.11$8,437$1,384.80+$104.37MHGGCF
5$907,965,307$796,282,558.81$9,013$1,875.40+$907.96MHGGCF
6$7,445,190,031$6,473,667,152.78$10,306$2,680.72+$7445.18MHGGCF
7$57,576,798,154$49,610,444,821.11$12,820$4,101.38+$57576.79MHGGCF
8$420,166,535,918$358,559,361,892.40$17,673$6,826.70+$420166.52MHGGCF
9$2,894,985,686,808$2,445,407,493,376.48$27,543$12,591.86+$2894985.66MHGGCF
10$18,844,438,678,417$15,746,803,993,532.36$49,560$26,258.71+$18844438.63MHGGCF

HGGCF vs PFE: Complete Analysis 2026

HGGCFStock

Highway 50 Gold Corp., an exploration stage company, engages in the acquisition, exploration, and evaluation of assets in North America. The company explores for Carlin-type gold deposits. Its projects portfolio includes the Gold Knob project comprises 687 unpatented claims located in Winnemucca, Nevada; the Golden Brew project that consists of 167 claims located in the Battle Mountain Mining District, Nevada; the Johnson Canyon project, which comprises 186 claims located in Lander County, Nevada; and the Monroe project covering an area of 1,282 hectares located in the Fort Steele Mining Division, Southeast British Columbia. The company was formerly known as Tatmar Ventures Inc. and changed its name to Highway 50 Gold Corp. in July 2011. Highway 50 Gold Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.

Full HGGCF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HGGCF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HGGCF vs SCHDHGGCF vs JEPIHGGCF vs OHGGCF vs KOHGGCF vs MAINHGGCF vs JNJHGGCF vs MRKHGGCF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.